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ABSTRACT: Intervertebral disc (IVD) degeneration is a common disorder of the lower spine. Since it is caused by loss of cellularity,
there is interest in the comprehension of the cellular phenotypes. This study aimed to verify if stem cells isolated from nucleus pulposus
of intervertebral discs (NPs-IVD), which may express neurogenic properties, may be implicated in IVD disease. NPs-IVD isolated from
14 human pathological discs were cultured under mesenchymal and neural differentiation. An induction of the neural markers GFAP,
NF, MAP2, O4, and a decrement of the expression of the immature neural markers b-tubulin III, Nestin, NG2, occurred within the
neural differentiation. The expression of TrkA and p75NGFR, the receptors of NGF, was not correlated with neural induction; in
contrast, TrkB, the BDNF receptor, increased and was co-expressed with acid sensing ion channel 3 (ASIC3). In the same condition,
neuroinﬂammatory markers were over-expressed. We conﬁrm our hypothesis that stem cells within IVD degeneration acquire neuro-
genic phenotype, causing the induction of markers related to inﬂammatory condition. These cells could promote the enrolment of neuro-
trophines in adaptation to the acidic microenvironment in degenerative conditions. These data could improve our knowledge about IVD
cellularity and eventually lead to the development of pharmacological therapies.  2012 Orthopaedic Research Society. Published by
Wiley Periodicals, Inc. J Orthop Res 30:1470–1477, 2012
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Low back pain is an extremely common symptom that
could affect nearly three-quarters of the population
sometime in their life. Ninety percent of the popula-
tion recovers within 3 months, but in some patients
chronic low back pain leads to long term physical dis-
ability and a reduced quality of life.1 The mechanism
of disc degeneration is thought to be caused by the in-
ability of the nucleus pulposus (NP) to maintain, after
stress conditions, a normal content of proteoglycans
and collagen, which are responsible for the trapping of
water via osmosis and negative charge.2 Studies based
on the characterization of the cells resident in the
niche of the intervertebral disc (IVD) have improved
our knowledge of the role of these cells and of their
plasticity.3
Risbud and colleagues4 found evidence of skeletal
progenitor cells in the degenerated cervical human
IVD, suggesting a role in orchestrating the repair
after degeneration. Despite this knowledge, all the
types of cells that populate the IVD and their role in
degenerative and regenerative process have yet to be
identiﬁed. In addition, it is also unknown if the immu-
nophenotypic and molecular properties, the prolifera-
tion and the differentiation abilities of these cells in
pathological conditions are defective. Moreover, NP
cells are in hypoxic conditions and cellular respiration
is largely anaerobic. The consequence of this anaerobic
microenvironment is the presence of low pH.5 In neu-
ral tissue, the adaptation to an acid niche is regulated
by the activation of acid sensing ion channel (ASIC)
proteins,6 that are implicated in pain transduction
associated with ischemic or inﬂamed tissue acidosis7
as in NP of IVD.8 ASIC3 is a voltage-independent,
depolarizing cationic channel mainly permeable to
Naþ ions9 that opens when pH drops in the extracellu-
lar environment.10 The channel has been associated
with inﬂammatory pain: mice lacking the ASIC3 chan-
nel do not develop chronic muscle pain from repeated
administration of an acidic saline.11 Experiments on
rats suggest that the activity of this channel protein
may serve to induce the IVD cells to express markers
related to hyperinnervation to adapt to the altered
environment in pathological conditions.12 Among the
molecules that are presumably involved in IVD hyper-
innervation, of great importance are the members of
the neurotrophins (NTs) family.13 NTs enhance the
survival and differentiation of different populations of
peripheral nerve neurons. Nerve growth factor (NGF)
and brain-derived neurotrophic factor (BDNF) have
been found to be increased in degenerated IVD.14
Moreover, degenerative conditions induce the expres-
sion of inﬂammatory molecules that could modify
the perception of pain. Calcitonin gene related peptide
(CGRP), an inﬂammatory neuropeptide associated
with pain and inﬂammatory state, is expressed on
IVD.15 The purpose of this study was to investigate
the features, the differentiation ability, and the role of
NPs-IVD in degeneration process by the expression of
markers involved in degenerative damage.
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METHODS
Isolation of Nucleus Pulposus Cells From Human Degenerated
IVD (NPs-IVD)
The study protocol was approved by our institutional ethics
committee and patients’ informed consents to the procedure
were obtained. In our study, samples of IVD were collected
from the lumbar column of 14 patients undergoing surgeries.
The samples were taken from 7 male and 7 female patients
with similar degenerative disc case histories. Lumbosacral
MRI of each patient was taken to assess Thompson degener-
ation grade. Samples, ranging between 3 and 6 g, of degener-
ated disc were removed, nucleus pulposus (NP) was
separated from the annulus ﬁbrosus (AF) using a stereotaxic
microscope, collected and placed in a falcon with Stem Cells
Medium (SCM), as previously described,16 supplemented
with 10% of fetal bovine serum (Gibco, Grand Island, NY)
and 1% penicillin and streptomycin solution (Sigma–Aldrich,
Basel, Switzerland). The tissues were maintained at 48C
overnight, then were enzymatically digested for 16 h by
means of Dulbecco’s medium (Gibco) supplemented with
0.25% Liberase Blendzyme2 (2.5 mg/ml, Roche Diagnostics,
Indianapolis, IA) in D-PBS, Dulbecco’s phosphate buffered
saline (Euroclone, Milan, Italy). The digested tissue/cell sus-
pension was passed through a 100 mm cell strainer (Falcon,
Becton Dickinson, Allschwil, Switzerland) to remove tissue
debris and centrifuged at 400g for 10 min. Human disc cells
were seeded in 75-cm2 (2  105 cells/cm2) and weekly were
detached from the tissue culture plates using Tryple Select
(Gibco). NPs-IVD were expanded for experimental uses
(2  104 cells/cm2) until at passage 10 (P10) in a humidiﬁed
atmosphere containing 5% CO2 at 378C. Cell viability was
assessed by Trypan Blue dye-exclusion assay.
Analysis of Apoptosis
To detect apoptosis in NPs-IVD, a DeadEND ﬂuorometric
TUNEL analysis (Promega, Madison, WI) was performed
according to manufacturer’s recommendations.
Flow Cytometric Immunophenotyping
For each sample, 5  104 cells were characterized by means
of FACS. Cells were incubated with appropriate phycoery-
trine (PE) or ﬂuorescein isothiocyanate (FITC) conjugated
antibodies to test the expression of a pattern of hematopoietic
and mesenchymal markers: CD14, CD24, CD44, CD45,
CD73, CD166 (BD Pharmingen, San Jose, CA), CD133/2, CD34
(Miltenyi Biotec, Bisley, Surrey, UK), CD105, (AbDSerotec,
Raleigh, NC), and CD90 (Millipore, Temecula, CA). After
30 min at 48C, cells were washed once with PBS, ﬁxed with
4% paraformaldehyde (PFA), and were analyzed using a
FACS scan ﬂow cytometer and Cell Quest software (BD
Pharmingen). Isotype-matched mouse immunoglobulins were
used as control.
Differentation Assay
Human Mesenchymal Stem Cell Functional Identiﬁcation
Kit (R&D Systems, Minneapolis, MN) was used to induce
adipogenic, chondrogenic, and osteogenic differentiation.
According to the kit, the expression of adipogenic, osteogenic,
and chondrogenic markers was tested, respectively, with
goat anti-mouse FABP-4 antibody, with mouse anti-human
osteocalcin antibody, and with goat anti-human aggrecan an-
tibody as reported in the procedure. Negative controls were
made to evaluate the speciﬁcity of the antibodies. Moreover,
NPs-IVD were plated in 4-well chamber slides coated with
collagen bovine type IV (BD Pharmingen) in the NEU medi-
um, the culture medium (SCM) deprived by mitogens (EGF
and bFGF) which facilitates the expansion of neural cells,
and 10% of fetal bovine serum (Gibco) for 2 weeks and ﬁxed
in 4% PFA. The positive expression for neural markers was
analyzed by means of immunostaining with lineage-speciﬁc
antibodies: GFAP (rabbit, 1:500), NG2 (rabbit, 1:200), b-III
tub (mouse, 1:100), neuroﬁlament, NF-150 KDa (rabbit,
1:100) (Chemicon, Temecula, CA); Nestin (mouse, 1:100;
R&D systems), MAP2 (mouse 1:100), and oligodendrocyte
marker O4 (mouse 1:20) (Boehringer-Mannheim, Indianapo-
lis, IN). TrkA (rabbit 1:100), p75NGFR (rabbit 1:500) AbCam,
Cambridge, MA), and TrkB (mouse 1:100) (Millipore) were
utilized to detect the expression of neurotrophins markers.
ASIC3 (goat 1:100, R&D System), Sodium Channel-pan (rabbit
1:100, Novus Biologicals, Littleton, CO) and CGRP (mouse
1:100, AbCam) immonostainings were carried out to evaluate
degeneration condition. After three washings nuclei were
counterstained with DAPI (1 mg/ml) (Chemicon), the cells
were incubated with appropriate secondary antibody and ﬁ-
nally were mounted with FluorsaveTM Reagent (Calbiochem,
Darmstadt, Germany) and viewed under a Zeiss Axiophot-2
microscope. Speciﬁcity of the secondary antibodies was con-
ﬁrmed by negatively staining cells with the secondary anti-
bodies alone, with no staining of >98% of the total cells.
Gene Expression Analysis
Three separate RNA extractions were performed on NPs-IVD
and processed separately. Total RNAs from each cell line
were isolated with TRIzol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s protocol. cDNA was pre-
pared from 1 mg RNA using SuperScript First- Strand Syn-
thesis Kit (Invitrogen). PCR ampliﬁcation primer pairs were
bought from Proligo Sigma (St. Louis, MO; Table 1). The
Table 1. Primers Utilized in PCR Analysis
Primer bp Ta (8C) Cycles
NGF Forward: CTG GCC ACA CTG AGG TGC AT 120 53 40
Reverse: TCC TGC AGG GAC ATT GCT CTC
BDNF Forward: AAA CAT CCG AGG ACA AGG TG 248 55 35
Reverse: AGA AGA GGA GGC TCC AAA GG
ASIC3 Forward: TAT GAG ACC GTG GAG CAG 331 58 30
Reverse: TGT GTG ACA AGG TAG CAG
GAPDH Forward: CGG AGT CAA CGG ATT TGG TCG TAT 309 58 35
Reverse: AGC CTT CTC CAT GGT GGT GAA GAC
bp, base pair; Ta, temperature of annealing in degree Celsius (8C).
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PCR products were visualized on ethidium bromide-stained
2% agarose gels and evaluated by transilluminator.
Statistical Analysis
The right number of replicates for each experiment in vitro
was determined on the basis of the inter- and intra-assay
variation (from 1% and 5%) of the single assay and the stan-
dard deviation of the results was shown. In Real Time a
p value of <0.05 was considered signiﬁcant. We repeated
each experiment at least three times.
RESULTS
Isolation of NPs-IVD
Cells isolated from NP of 14 human degenerated IVD
samples after 1 day of culture in SCM supplemented
with 10% FBS showed initially a neurosphere-like
morphology. After 14 days in vitro, some cells dis-
played ﬂoating macroaggregates while other cells dem-
onstrated polygonal morphology and during passages,
monolayer cultured cells remained adherent; however as-
suming a neural/astrocyte like cells morphology (Fig. 1A).
The apoptotic analysis with TUNEL test revealed that a
small number of cells (7.23  2.5%) showed the degrada-
tion of DNA in membrane blebbing (Fig. 1B). The per-
centage of apoptotic cells was calculated by FACS
analysis with Annexin V. Moreover, a double staining
procedure with propidium iodide was performed to distin-
guish apoptotic from necrotic cells. In fact, apoptotic cells
were Annexin Vþ/propidium iodide (6.51  3.80%),
while necrotic cells were Annexin Vþ/propidium iodideþ
(0.01  0.01%) (Fig. 1C).
Figure 1. Isolation of NPs-IVD: (A) Growth curve and photographs of NPs-IVD morphology in different time of culture. (B) TUNEL
test and (C) FACS analysis revealed the low percentage of apoptotic and necrotic cells.
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NPs-IVD ExpressMesenchymalMarkers andDifferentiation
Properties
Immunophenotypic FACS analysis showed that the
NPs-IVD population, kept in culture in SCM, expressed
high percentage of positivity for CD24, CD44, CD73,
CD90 CD105, and CD166, a lower positivity fraction
for CD34, they were negative for CD14 and for CD45
and the expression of CD133 was unconsiderable
(0.59%) (Fig. 2A). Adherent NPs-IVD were cultured for
14 days under conditions that promoted the differenti-
ation towards chondrogenic, adipogenic, and osteogen-
ic lineages. Immunoﬂuorescence analyses of NPs-IVD
were performed to analyze the expression of lineage
speciﬁc markers. NPs-IVD cultured in chondrogenic me-
dium, expressed positivity for aggrecan (93.81  5.52%),
a marker used to evaluate deposition of proteoglycans.
When treated with adipogenic medium, fatty acid
binding protein 4 (FABP-4) expressions was 84.30 
6.85%. Moreover, NPs-IVD acquire osteocalcin marker
(92.65  4.48%) (Fig. 2B).
NPs-IVD Differentiate Into a Neurogenic Phenotype
To study neurogenic differentiation, NPs-IVD were
cultured on collagen coated chamber slides in NEU
medium supplemented with 10% of fetal bovine
serum for 14 days. The positive expression of NPs-IVD
for neural markers was analyzed by means of immuno-
staining with neural lineage-speciﬁc antibodies and a
comparison with NPs-IVD cultured in basal medium
(SCM) was done (Fig. 3A). NP-IVDs, already highly
positive for btub III (75.45  11.80%) and nestin (67.62 
14.50%) in basal condition, under differentiation stimuli,
Figure 2. Mesenchymal Proﬁle of Human NPs-IVD: (A) Immunophenotypic proﬁle, by citoﬂuorimetric analysis, of nucleus pulposus
from 14 human degenerated intervertebral discs. (B) NPs-IVD show mesenchymal properties under chondrogenic, adipogenic, and
osteogenic differentiation.
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become highly positive also for GFAP (39.29  3.29%),
NF (69.14  31.43%), NG2 (50.91  26.90%), O4
(22.36%  0.65%), and MAP2 (83.01  6.91%) (Fig. 3B).
In addition, the cell population cultured in SCM
medium, co-expressed with high positivity b-tub III
and GFAP (b-tub III/GFAP 51.93  3.37%) (Fig. 3C);
while, upon differentiation conditions, a modest co-
expression (14.3  3.8%) was found within NPs-IVD
(Fig. 3D). The expression of TrkA (70.63  13.19%),
p75NGFR (74.01  19.52%), and TrkB (98.5  1.20%)
were also evaluated. The analysis of ASIC3, TrkA, and
TrkB showed a great number of cells that co-localized.
Almost 100% of cell population positive for ASIC3, co-
expressed with TrkA and TrkB (Fig. 4A,B). In neural
differentiation conditions, the positivity for inﬂamma-
tory markers Sodium Channel-pan (87.24  15.41%)
and CGRP (73.95  12.76%) (Fig. 4C,D) was higher
than in the basal condition. Moreover there was a co-
localization between p75NGFR and CGRP (Fig. 4E).
The expression level for TrkB is signiﬁcantly elevated
Figure 3. Neurogenic phenotype of NPs-IVD: (A) Histograms show the % of positive cells with standard deviation expressing imma-
ture and mature neural markers in basal condition (SCM) and under neural differentiation (NEU medium) examined by immunoﬂuo-
rescence analysis. p < 0.05; p < 0.01. (B) Neural markers immuno-reactivity. (C,D) The ring charts show the relative distribution of
the co-localization b-tub III and GFAP in basal and neural condition. Black part corresponds to the cells that do not express the
mentioned markers; yellow part corresponds to the cells that co-localized the two markers. [Color ﬁgure can be seen in the online
version of this article, available at http://wileyonlinelibrary.com/journal/jor]
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after neural differentiation, while no differences in the
expression for TrkA and p75NGFR were found (Fig.
4F). Moreover, PCR analysis of neural differentiated
NPs-IVD indicated that the cells expressed NGF,
BDNF and ASIC3 mRNA. Similarly, NGF, BDNF, and
ASIC3 mRNAs expression was found in the brain, the
control sample (Fig. 4G).
DISCUSSION
In the present study we describe the characterization
of the phenotype of NPs-IVD. Two major issues are
addressed: 1) the identiﬁcation of cells isolated from
NP of human IVD with mesenchymal proﬁle that can
differentiate into neural phenotype; 2) degenerated
NPs-IVD that, by the expression of ASIC3 and CGRP,
Figure 4. Expression of neurotrophic and neuroinﬂammatory markers: (A,B,E) NPs-IVD express markers related to the acidic
microenvironment and an inﬂammatory state: TrkA and TrkB with colocalization with ASIC3, and p75NGFR with colocalization
with CGRP. The ring charts show the single expression or the yellow double-labeling expression of the markers. Black part corresponds
to the cells that do not express the mentioned markers. (F) Histograms show the % of positive cells with standard deviation of
neurotrophic and inﬂammatory markers related to basal and neural differentiation culture conditions p < 0.05; p < 0.01. (C)
Sodium Channel-pan and (D) CGRP expressions. (G) PCR analysis was performed in three samples (n ¼ 1, 2, 3) of NP-IVDs of BDNF,
NGF, and ASIC3 related to adult brain, the control sample. GAPDH was used as a housekeeping gene. [Color ﬁgure can be seen in the
online version of this article, available at http://wileyonlinelibrary.com/journal/jor]
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could be responsible for hyperinnervation due to the
acidic microenvironment contributing to the degenera-
tion process. NPs-IVD express the majority of cell
surface antigens expressed in mesenchymal cells,
CD44, CD73, CD90, CD105, and CD 166 and show
plastic adherent ability.17 They express CD24, a glyco-
sylphosphatidylinositol anchor protein, a cell surface
marker for NP,18 while they are less positive for CD34
and negative for CD14 and CD45, which mark primi-
tive hematopoietic progenitors and endothelial cells.
The expression of CD133, evaluated by FACS analysis,
was inconsiderable (0.59%), showing a phenotypic pro-
ﬁle of mesenchymal stem cells.19 Moreover, these cells
demonstrate a high level of multipotenciality as they
could induce the expression of adipogenic, osteogenic,
chondrogenic, and neural markers, in the presence of
appropriate stimuli. Our study is comparable to the
recent work of Feng and colleagues, who showed the
expression of neurogenic markers in AF cells. They
reported that cells from nondegenerative IVD of ado-
lescent patients with idiopathic scoliosis, if cultured
under media containing different stimuli, are able to
express neural markers such as b-tub III, Nestin,
and MAP2.20 It is important to highlight that our
data refer to NP, the inner part of the IVD and that
show an over-expression of neural and inﬂammatory
markers in neural induction. Similarly to our data,
the recent work published by del Can˜izo et al., showed
the presence of mesenchymal stem cells from NP of
degenerated IVD. They identiﬁed a population of
mesenchymal stromal cells able to differentiate into
chondrogenic and osteogenic lineages. In contrast to
our results they did not report the differentiation of
their cells into an adipogenic lineage.3 Notably, the ex-
pression of Nestin has previously been demonstrated
to have an important role in allowing MSC derived
from adult bone marrow to commit to a neural and as-
trocytic fate.21 Here we show that Nestin is expressed
in NPs-IVD, which could explain why these cells are
able to express markers of neuronal, astrocytic, and
oligodendrocytic lineages in differentiation condition.
In addition, the cells cultured in basal condition, show
co-expression of b-tub III and GFAP, suggesting that
they could be in the progenitor stage (or glioblast) of
neurogenic differentiation.22 The high expression of
neurotrophins, such as NGF and BDNF, resulting
from immunohistochemical and molecular analyses,
seems to show their important role in the degenerative
condition when there is hyperinnervation phenome-
non. Kirschenbaum and colleagues23 explained that in
degenerated IVD there is an overexpression of BDNF
that could promote the neural differentiation and sur-
vival of newly generated subventricular zone daughter
cells. Yamauchi et al.13 described that NGF, from the
NP, promotes the growth of sensory nerve ﬁbres inner-
vating the degenerated IVD. Sugiura24 investigated
the presence of TrkA and p75NGFR in a rat model,
illustrating high expression of these two receptors in
the superﬁcial part of the AF. Moreover, Gruber and
colleagues reported the presence of BDNF and its
receptor mRNA in the human outer annulus, inner an-
nulus, and nucleus pulposus of degenerated IVDs.25
Recently, the expression of mRNA of NGF was
reported in the article of Ponnappan and colleagues.
The authors showed the expression of NGF mRNA in
a model of organ culture of degenerated IVD.26 This
point is interesting because, as suggested, the expres-
sion of NT receptors is evident in basal and in neural
differentiation conditions and it can be possible that
the ligands expression have the same behaviour of
their receptor after neural induction. Furthermore,
additional molecular and pharmacological studies are
needed to support this hypothesis. Purmessur and
colleagues,27 investigated the expression of TrkA and
TrkB in NP of healthy and degenerated IVD, associat-
ing their expression with the severity of disc degenera-
tion in cells derived from the human IVD. As indicated
in our results, they showed the immunopositivity for
TrkA and TrkB in degenerated IVD. Moreover, our
data illustrated the positive expression of TrkB that
increased under neural differentiation. The signiﬁ-
cance of this increment could be explained by suggest-
ing an autocrine effect on the neural disc cells
themselves in degeneration conditions. Moreover,
the co-localization of TrkA and TrkB sites banding
proteins with ASIC3 suggests a possible correlation be-
tween the acidic environments with the hyperinnerva-
tion condition. Almost 100% of ASIC3-positive NPs-
IVD, express TrkA and TrkB receptors. The presence
of the cells which co-express ASIC3 and TrkA or TrkB,
could be explained by the fact that some cells are more
responsive than others to the stress conditions of the
microenvironment. Furthermore, our results evidence
the over-expression of CGRP in neural differentiation.
Recently, was reported that DRG neurons innervating
punctured rats IVD were positive for CGRP and the
administration of a toxin able to destroy p75NGFR,
can induce the suppression of CGRP. Thus, p75NGFR
may be an important receptor to mediate discogenic
pain via CGRP expression.28 The origin of NPs-IVD
within human degenerated IVD with neurogenic dif-
ferentiation potential is not easy to explain. These
cells may be derived from the vertebral column. The
IVD, in fact, is derived from the notochorda and some
notochordal cells remain in the adult IVD.29 It is
possible that cells, quiescent for all their life, become
active and subsequently express neurogenic properties
in response to degeneration conditions. Probably,
due to the acidic microenvironment, they are able to
express neurotrophic factors in order to adapt to their
unique, hydrodynamically degenerated condition.
A study of this nature is critical for better compre-
hension of the disease process. Isolation of stem cells
from pathological IVD could represent a good tool to
understand more clearly the pathological mechanisms
that underlie IVD degeneration, to develop an in vitro
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model of IVD for pharmacological studies and eventu-
ally, to allow cell transplantation as a regeneration
therapy.
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